aXichem Continues to Receive Orders from Uriach under the Agreement Regarding a New Melatonin Formula
aXichem AB (publ), a pioneer in the development and marketing of natural analogue industrial chemicals, is pleased to announce new orders for aXivite[®] from Uriach, a renowned and expanding European pharmaceutical company. The order is related to the production of a new melatonin formula for Uriach’s brand Aquilea[®] featuring aXivite[®]. The first order was announced in November 2023, and with the additional orders placed, the total order value from Uriach, to date, amounts to about 60,000 Euro. “We're delighted with this progress and eager to further develop our collaboration with